iSpecimen

ISPC · NASDAQ

$0.9599−$0.0399 (−3.99%)TodayMarket closed ·
Prev close $0.9998

About ISPC

iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. The company is headquartered in Woburn, Massachusetts and currently employs 7 full-time employees. The company went IPO on 2021-06-17. The firm addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.

Employees
24
Headquarters
Woburn, Massachusetts
Listed
Jun 17, 2021
Sector
Health Care
Industry
Health Care Technology

Leadership

iSpecimen executives
NameTitleSince
Katharyn Field—2024
Yuying Liang——
Avtar Dhaliwal——
Anthony Lau——
Arphing Lee——

Revenue by product and region

Fiscal year ended Dec 31, 2023: $9.93M total revenue

By product

  • Specimens$9.36M94.3%
  • Shipping and other$566.46K5.7%

Similar companies

Companies in the same industry as iSpecimen

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.